Back

Biomarker-driven anti-inflammatory therapies for cardiovascular disease: state of the art.

29 June 2021 (08:25 - 08:37)
Organised by:
Congress Presentation Part of: Inflammation: cause or consequence of cardiovascular disease? or both? Leukocytes, Inflammation, Immunity HFA Premium Access Heart Failure 2021

About the speaker

Photo
Professor Thomas Felix Luescher

Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)

2 More presentations in this session

Presentation thumbnail
Leukocytes link local and systemic inflammation in ischaemic cardiovascular disease: an expanded 'cardiovascular continuum'.
Professor F. Leuschner (Heidelberg, DE)
Slides Video
Presentation thumbnail
Systemic inflammation and heart failure: lessons from rheumatoid arthritis.
Doctor S. Toldo (Richmond, US)
Slides Video

Access the full session

Session thumbnail
Inflammation: cause or consequence of cardiovascular disease? or both?
Video

The Event

Event poster

Heart Failure 2021

29 June 2021 08:25 CET
You may be interested in
thumbnail
Webinar
Quantification of coronary inflammation using coronary CT angiography to improve patient risk prediction and stratification
27 September 2021
thumbnail
Congress Presentation
Investigation of biomarker response to SGLT2 Inhibition in heart failure (SiN-HF)
30 August 2025
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
17 December 2024
thumbnail
Webinar
Recent advances in immune pathways in atherosclerosis
21 April 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources